Navigation Links
New Non-Surgical Laser Treatment Helps Patients Live Pain Free

Low level laser therapy (LLLT), also called cold laser therapy, is a new treatment that provides proven pain relief and healing without drugs or surgery. This innovative pain relief therapy is now offered by The Laser Pain Management Center in Western Massachusetts.

Holyoke, Mass. (Vocus) May 27, 2009 -- Persistent pain can have an adverse affect on every aspect of daily life. Low level laser therapy (LLLT), which is now approved by the U.S. Food and Drug Administration (FDA), provides the very latest in safe, non-invasive treatment options for people with acute and chronic pain that has not responded to other types of treatment. LLLT is used to treat a wide variety of conditions, including back and neck pain, arthritis, carpal tunnel syndrome, fibromyalgia, post-surgical pain, and injuries.

“Pain often interferes with family life, work, and leisure activities, and can force you to make drastic changes in the way you live,” says board-certified physician and surgeon, Stanley J. Swierzewski III, M.D. “Laser pain management is an innovative treatment that utilizes the most up-to-date medical technology to promote pain relief and healing, reduce inflammation, improve blood flow and range of motion, and stimulate the immune system—without drugs or surgery.”

Dr. Swierzewski and other members of the highly-qualified medical team at The Laser Pain Management Center now offer low level laser therapy (LLLT) for pain management. According to Dr. Swierzewski, “Laser treatments take just a few minutes, but the therapeutic effects continue to soothe and heal long after the treatment session. There is no discomfort during treatment—simply a deep, gentle warmth as your body responds to the light.”

Low level laser therapy, LLLT, also called cold laser therapy, causes no known risks or side effects and provides long-lasting pain relief. The light energy from low level lasers cannot cause burns or tissue damage. Each treatment session lasts only about 5–10 minutes and, although the full benefits of LLLT may require several treatment sessions, many patients experience significant improvement after the very first treatment. Low level laser therapy can be used alone or in combination with other treatments, such as physical therapy, massage therapy, chiropractic therapy, and acupuncture.

During low level laser therapy, light energy from hand-held lasers penetrates deep into the muscles, joints, bones, and tendons. This laser light stimulates a biochemical reaction that helps to repair damaged tissue and promote healing. LLLT provides faster results, as well as a high rate of patient satisfaction, and requires shorter treatment times than many other pain relief methods.

Many people who currently suffer with chronic pain may find relief through cold laser therapy. To learn more, including answers to frequently asked questions about low level laser therapy, visit The Laser Pain Management Center’s website at The Center’s staff of experienced medical professionals welcomes inquiries and is eager to help people take the first steps toward living pain free.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. ZERONA™ Laser Liposuction: New Non-Surgical, Pain-Free Technology Emerges in the Los Angeles Area
2. Non-Surgical Clubfoot Treatments Bring High Level of Success
3. Dr. Lisa Zdinak Announces, CO2TouchTM Brazilian Carboxytherapy - New Technology for Non-Surgical Treatment of Stretch Marks, Cellulite and Dark Undereye Circles
4. Non-Surgical Approach Can Treat Lung Cancers
5. New Non-Surgical Stem-Cell Procedure Relieves Degenerative Joint Disease
6. Newly Published Study in Leading Medical Journal Further Confirms the Brava Systems Non-Surgical Breast Enhancement Effectiveness
7. Prominent Farmington Plastic Surgeon Uses Two New Non-Surgical Procedures to Tighten Skin and Remove Fat
8. New Clinical Data Shows Significant Improvement in the Appearance of Fat Using SlimLipo(TM) Laser
9. BioHorizons Reports on Comparative 3-Year Dental Implant Study Showing Significant Crestal Bone and Soft Tissue Retention Using Laser-Lok(R) Microchannels
10. Treating Untreatable Brain Tumors: FDA Approves New Laser Surgery
11. Cynosure Enhances Industry-Leading Smartlipo Laser Lipolysis Workstation with Increased Energy and Intelligent Temperature Sensing
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... An ... directory is specialized and only includes chiropractic clinics in the US. , The ... trustworthy alternative health practitioner when back pain sets in. When people are experiencing ...
(Date:11/30/2015)... ... November 30, 2015 , ... In ... Halloween festivities, the Word of Life Christian Church of Flint, MI, hosted a ... a giant 1.25 ton pile of candy dubbed “Candy Mountain”. , A Forever ...
(Date:11/30/2015)... ... November 30, 2015 , ... During ... fundraising campaign to raise funds for its research, education, support, and advocacy efforts. ... organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also goes by ...
(Date:11/30/2015)... ... November 30, 2015 , ... The ... in Dallas, TX, on January 29 and 30, 2016. The course welcomes dental ... of their practices, to learn how to better succeed in the modern dental ...
(Date:11/30/2015)... ... November 30, 2015 , ... HemoTreat™ has announced that the ... ointment to its website. , “Our goal is simple:” says Michael Blasco, HemoTreat’s ... the comparison chart and ingredient list allows our customers to quickly see why, ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... Free Press as a Top Workplace , among the ... work for in 2015. ... annually, based on employee surveys rating company leadership, career opportunities, ... based solely on employee feedback. The survey is conducted by ...
(Date:11/30/2015)...  IBA Molecular North America, Inc. (IBAMNA), a U.S. ... that as of January 1, 2016, it will do ... to rebrand the company reflects a refined vision for ... close relationship with Zevacor Molecular.  Both IBAMNA and Zevacor ... Peter Burke , Vice President Sales ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: